Seegene RV assay gets CE-IVD mark, Australian TGA approval

Create PDF

June 2022—Seegene announced that its Allplex RV Master Assay has achieved CE-IVD marking and received approval from Australia’s Therapeutic Goods Administration.

The Allplex RV Master Assay can identify three genes of COVID-19, flu A, flu B, metapneumovirus, two types of respiratory syncytial virus, four types of parainfluenza virus, six types of adenovirus, and three types of human rhinovirus.